Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01141959 · ClinicalTrials.gov registry record
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
A clinical trial, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 11
- Enrollment target
NCT01141959 is a clinical trial that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 11 participants.
The verdict
NCT01141959 has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The investigators are interested in identifying patient-specific factors related to donor chimerism in patients who receive nonmyeloablative hematopoietic stem cell transplants from haploidentical donors. We will look how patients' bodies break down and immediately respond to cyclophosphamide, fludarabine and mycophenolate mofetil.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01141959
The ClinicalTrials.gov registry entry for NCT01141959 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01141959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01141959 about?
NCT01141959 is a clinical study titled "Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients". The investigators are interested in identifying patient-specific factors related to donor chimerism in patients who receive nonmyeloablative hematopoietic stem cell transplants from haploidentical donors. We will look how patients' bodies break down and immediately respond to cyclophosphamide, fluda...
What is the current status of trial NCT01141959?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2010-05. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01141959?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.